Patents by Inventor Steve W. Ludmerer

Steve W. Ludmerer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICRORNA BIOMARKERS OF TISSUE INJURY
    Publication number: 20110111976
    Abstract: One aspect of the invention generally relates to use of tissue enriched miRNAs as biomarker to estimate tissue damage in a fluid sample. In a second aspect, methods are provided for monitoring a subject who is exposed or might have been exposed to an agent that has a risk of causing tissue injury. In a third aspect, methods are provided for identifying an agent as having a risk of causing tissue injury to a vertebrate subject. In a fourth aspect, kits are provided for practicing the methods of above-listed aspects. The contents of this ABSTRACT are not intended to in anyway limit the scope of the inventions claimed herein.
    Type: Application
    Filed: April 24, 2009
    Publication date: May 12, 2011
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Thomas L. Fare, Philip W. Garrett-Engele, Warren E. Glaab, Jason M. Johnson, Omar F. Laterza, Lee Lim, Steve W. Ludmerer, David B. Olsen, Joseph F. Sina, Frank D. Sistare
  • GABA-gated chloride channels
    Patent number: 7220832
    Abstract: The present invention features Dermacentor variabilis GABA-gated chloride channel polypeptides and nucleic acids, and uses of such polypeptides and nucleic acids. D. variabilis is a widely distributed tick associated with different diseases. A preferred use of the present invention is to obtain compounds for preventing or treating a tick infestation.
    Type: Grant
    Filed: March 28, 2001
    Date of Patent: May 22, 2007
    Assignee: Merck & Co., Inc
    Inventors: Yingcong Zheng, Doris F. Cully, Steve W. Ludmerer
  • DERMACENTOR VARIABILIS GABA-GATED CHLORIDE CHANNELS
    Publication number: 20030208041
    Abstract: The present invention features Dermacentor variabilis GABA-gated chloride channel polypeptides and nucleic acids, and uses of such polypeptides and nucleic acids. D. variabilis is a widely distributed tick associated with different diseases. A preferred use of the present invention is to obtain compounds for preventing or treating a tick infestation.
    Type: Application
    Filed: September 25, 2002
    Publication date: November 6, 2003
    Inventors: Yingcong Zheng, Doris F. Cully, Steve W. Ludmerer